XML 15 R49.htm IDEA: XBRL DOCUMENT v3.19.3
Equity Financing - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 17, 2018
Aug. 14, 2018
Feb. 28, 2018
Jan. 31, 2017
Sep. 30, 2016
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Jan. 31, 2019
Dec. 31, 2018
Apr. 30, 2017
Subsidiary Sale Of Stock [Line Items]                      
Common stock sold             $ 984,000     $ 952,000  
2017 Placement Warrants                      
Subsidiary Sale Of Stock [Line Items]                      
Warrants to purchase common stock, shares       1,720,512              
Warrant exercise price       $ 3.17     $ 3.17        
Warrant expiration date       Jan. 31, 2024              
Warrant exercisable date       Jul. 31, 2017              
Warrant expiration period       7 years              
2016 Placement Warrants                      
Subsidiary Sale Of Stock [Line Items]                      
Warrants to purchase common stock, shares         1,380,745            
Warrant exercise price         $ 2.95   $ 2.95        
Warrant expiration period         7 years   7 years        
Underwriters | Common Stock                      
Subsidiary Sale Of Stock [Line Items]                      
Underwriting agreement date   Aug. 14, 2018                  
Number of shares issued in transaction   16,216,217                  
Sale of stock, price   $ 9.25                  
Option to purchase additional shares   30 days                  
Aggregate proceeds from issuance of common stock $ 161,900,000                    
Underwriters | Common Stock | Maximum                      
Subsidiary Sale Of Stock [Line Items]                      
Number of additional shares issued in transaction   2,432,432                  
March 2018 Direct Registered Offering                      
Subsidiary Sale Of Stock [Line Items]                      
Proceed from private placement and equity issuances, gross     $ 59,100,000                
March 2018 Direct Registered Offering | Common Stock                      
Subsidiary Sale Of Stock [Line Items]                      
Stock issued during period     4,090,000                
March 2018 Direct Registered Offering | Series A Convertible Preferred Stock                      
Subsidiary Sale Of Stock [Line Items]                      
Stock issued during period     3,000,581                
March 2018 Direct Registered Offering Warrants                      
Subsidiary Sale Of Stock [Line Items]                      
Warrants to purchase common stock, shares     1,418,116                
Warrant exercise price     $ 8.31                
Warrant expiration date     Mar. 31, 2025                
2017 Private Placement | Common Stock                      
Subsidiary Sale Of Stock [Line Items]                      
Number of shares issued in transaction       8,602,589              
Proceed from private placement and equity issuances, gross       $ 26,100,000              
2016 Private Placement | Common Stock                      
Subsidiary Sale Of Stock [Line Items]                      
Number of shares issued in transaction         4,602,506            
Proceed from private placement and equity issuances, gross         $ 13,800,000            
At The Market Offering Program                      
Subsidiary Sale Of Stock [Line Items]                      
Aggregate proceeds from issuance of common stock             $ 0 $ 278,000      
Common stock sold           $ 300,000 $ 40,400,000 $ 300,000      
At The Market Offering Program | Maximum                      
Subsidiary Sale Of Stock [Line Items]                      
Maximum aggregate offering price       $ 75,000,000         $ 250,000,000    
Maximum common stock saleable shares, value                 $ 100,000,000   $ 50,000,000
At The Market Offering Program | Common Stock                      
Subsidiary Sale Of Stock [Line Items]                      
Stock issued during period           18,648,649   18,681,746